Mutational profiling of acute lymphoblastic leukemia with testicular relapse.

Ling-Wen Ding, Qiao-Yang Sun, Anand Mayakonda, Kar-Tong Tan, Wenwen Chien, De-Chen Lin, Yan-Yi Jiang, Liang Xu, Manoj Garg, Zhen-Tang Lao, Michael Lill, Henry Yang, Allen Eng Juh Yeoh, H Phillip Koeffler
Author Information
  1. Ling-Wen Ding: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. csidlw@nus.edu.sg.
  2. Qiao-Yang Sun: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  3. Anand Mayakonda: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  4. Kar-Tong Tan: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  5. Wenwen Chien: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  6. De-Chen Lin: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  7. Yan-Yi Jiang: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  8. Liang Xu: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  9. Manoj Garg: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  10. Zhen-Tang Lao: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  11. Michael Lill: Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, USA.
  12. Henry Yang: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  13. Allen Eng Juh Yeoh: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. allen_yeoh@nuhs.edu.sg.
  14. H Phillip Koeffler: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.

Abstract

Relapsed acute lymphoblastic leukemia (ALL) is the leading cause of deaths of childhood cancer. Although relapse usually happens in the bone marrow, extramedullary relapse occasionally occurs including either the central nervous system or testis (<1-2%). We selected two pediatric ALL patients who experienced testicular relapse and interrogated their leukemic cells with exome sequencing. The sequencing results and clonality analyses suggest that relapse of patient D483 directly evolved from the leukemic clone at diagnosis which survived chemotherapy. In contrast, relapse leukemia cells (both bone marrow and testis) of patient D727 were likely derived from a common ancestral clone, and testicular relapse likely arose independently from the bone marrow relapsed leukemia. Our findings decipher the mutational spectra and shed light on the clonal evolution of two cases of pediatric ALL with testicular relapse. Presence of CREBBP/NT5C2 mutations suggests that a personalized therapeutic approach should be applied to these two patients.

Keywords

References

Nature. 2011 Mar 10;471(7337):189-95 [PMID: 21390126]
Nat Commun. 2014 Mar 24;5:3469 [PMID: 24662245]
Cancer Res. 2017 Jan 15;77(2):390-400 [PMID: 27872090]
Nat Genet. 2013 Mar;45(3):290-4 [PMID: 23377183]
Nat Med. 2013 Mar;19(3):368-71 [PMID: 23377281]
Leukemia. 2012 Aug;26(8):1797-803 [PMID: 22388726]
Nature. 2011 Mar 10;471(7337):235-9 [PMID: 21390130]
Nat Commun. 2015 Mar 19;6:6604 [PMID: 25790293]
Genome Biol. 2015 May 06;16:91 [PMID: 25944252]
Nat Immunol. 2013 Oct;14(10):1084-92 [PMID: 23974956]

MeSH Term

Child, Preschool
Clonal Evolution
DNA Mutational Analysis
Humans
Infant
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Recurrence
Testicular Neoplasms

Word Cloud

Similar Articles

Cited By